Please assess the completion status of the following clinical trial:

Trial Title: Effect of Adaptive Servo Ventilation (ASV) on Survival and Hospital Admissions in Heart Failure

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* American Heart Association Stage B-D Heart failure due to ischemic, idiopathic or hypertensive causes, present for at least 3 months~* Left Ventricular Ejection Fraction ≤ 45 %~* Optimal medical therapy for heart failure~* No change in active cardiac medications for 2 weeks prior to randomization, beta-blockers must be started 3 months prior to randomization~* Sleep apnea with an AHI ≥ 15. Subjects with obstructive sleep apnea must also have an Epworth Sleepiness Scale score of ≤ 10 and no or mild daytime sleepiness~* Written informed consent~Exclusion Criteria:~* Heart failure due to primary valvular heart disease~* Presence of moderate to severe mitral insufficiency due to intrinsic mitral valve disease~* Hypertrophic obstructive or restrictive or post partum cardiomyopathy~* Exercise capacity limited by class IV angina pectoris~* Acute MI, cardiac surgery, PCI, AICD, or CRT within 3 months of randomization~* Active myocarditis~* Planned AICD or CRT~* Presence of a left-ventricular assist device~* Transplanted heart or expected to receive a transplanted heart within the next 6 months~* Pregnancy~* Current use of ASV or CPAP or mandibular advancement device for treatment of sleep apnea or treated with any investigational therapy during the last 4 weeks (including approved therapies being used in unapproved indications)~* A clinical history that would interfere with the objectives of this study or that would in the investigator's opinion preclude safe conclusion of the study~* Any other medical, social, or geographical factor, which would make it unlikely that the patient will comply with the study procedures (e.g. alcohol abuse, lack of permanent residence, severe depression, disorientation, distant location, or history of non-compliance)~* Any contraindication to ASV therapy as detailed in the device provider manual

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Standard HF therapy (Type: NO_INTERVENTION): Subjects will receive optimal standard therapy for heart failure conforming to national guidelines as determined by the referring cardiologist
- Standard therapy for HF + ASV (Type: ACTIVE_COMPARATOR): Subjects will receive treatment with Adaptive Servo Ventilation in addition to optimal standard therapy for heart failure conforming to national guidelines, as determined by the referring cardiologist

Based on this trial design, predict the completion outcome and termination type (if applicable).